Compare companies
Put any US companies we track side by side — SEC-sourced financials, ratios, forensic scores, and our Quality Score. Add up to four. No market price, no paywall.
Senti Biosciences Holdings, Inc.
| Metric | Senti Biosciences Holdings, Inc. SNTIHealthcare |
|---|---|
| Quality Score | 46 / 100 |
| Revenue (latest) | $22,000 |
| Net income (latest) | −$61M |
| Operating margin | −312631.8% |
| Net margin | −279263.6% |
| Return on equity | −1099.3% |
| Return on assets | −119.9% |
| Return on capital (ROCE) | −184.6% |
| Debt / equity | 8.16× |
| Revenue growth (YoY) | — |
| Altman Z″ (distress) | -30.52 |
| Accruals / assets | −35.1% |
Latest reported figures from each company's own SEC filings (XBRL) plus our derived scores. Blank where a line item isn't cleanly tagged — never estimated. Descriptive factors, not advice. Open a company for its full multi-year history.